Dexmethylphenidate Hcl is the dextrorotatory enantiomer of methylphenidate, prescribed for attention deficit hyperactivity disorder (ADHD). Aloglutamol can cause an increase in the absorption of ...

CTx-1301 is designed to deliver 3 separate releases of medication at different times and in different ratios. Topline data were announced from a phase 3 trial evaluating CTx-1301 for the treatment of ...

Avoid alcohol intake while using Dexmethylphenidate as it can cause side effects like drowsiness, dizziness and impaired concentration (1 Trusted Source National Institute on Alcohol and Alcoholism.

A Prescription Drug User Fee Act target date of May 31, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ...

KANSAS CITY, Kan., June 08, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...

KANSAS CITY, Kan., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (CING) (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...

KANSAS CITY, Kan., May 20, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...

Please provide your email address to receive an email when new articles are posted on . Azstarys had a favorable safety profile, demonstrated efficacy and was well-tolerated compared to other ...

KANSAS CITY, Kan., July 11, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...